Some clinical evidence of the hypothesis of an indirect antiviral effect of propranolol through immunoactivation.
The hypothesis of an indirect antiviral effect on the immune system of propranolol has been confirmed on a small scale by treating viral infections with herpes simplex I, shingles and influenza virus infections diagnosed clinically; in one case influenza virus infection was confirmed with a specific influenza test. Herpes simplex infections were treated successfully with propranolol in 2 days, influenza infections in 2 to 3 days, chronic shingles lesions in a month. Other interesting effects of propranolol have been observed, for example on the skin, the liver, the pancreas and on the nervous system.